Got story updates? Submit your updates here. ›
Advanced manufacturing capabilities bolster the UK’s provide of important medicines and guarantee dependable entry to the most recent remedies.Haverhill TodayThe UK authorities is unlocking over £80 million in new investments for the nation’s life sciences sector, supporting the manufacturing of important medicines and creating over 500 extremely expert jobs. The funding, delivered by way of the Life Sciences Innovative Manufacturing Fund (LSIMF), will strengthen regional life sciences clusters and assist advance the federal government’s Life Sciences Sector Plan.
Why it issues
These investments will bolster the UK’s provide of crucial medicines, making certain dependable entry to the most recent and greatest remedies for folks residing with situations like most cancers, bipolar dysfunction, and neurodegenerative illnesses. The funding additionally helps the federal government’s aim of constructing the UK a worldwide hub for life sciences innovation and manufacturing.
The particulars
The £80 million in new investments features a £45 million dedication from Accord Healthcare to spice up manufacturing of oncology and chemotherapy medicines at its Barnstaple website, in addition to £10 million for the University of Birmingham’s Precision Health Technologies Accelerator to determine a brand new biomanufacturing facility. Codis can be investing in a brand new spray-drying facility in Haverhill, Suffolk to assist the event of next-generation therapies. These tasks will create over 500 new jobs and safeguard 160 extra throughout the nation.
- The investments had been introduced on April 14, 2026 by the UK’s Science and Technology Secretary Liz Kendall.
- The authorities’s Life Sciences Innovative Manufacturing Fund (LSIMF) has now unlocked £600 million in complete life sciences investments to date this yr.
The gamers
Liz Kendall
The UK’s Science and Technology Secretary, who introduced the brand new life sciences investments.
Zubir Ahmed
The UK’s Health Innovation and Safety Minister, who commented on the significance of those investments for offering sufferers entry to cutting-edge medicines.
Accord Healthcare
One of the biggest suppliers of oncology and chemotherapy medicines in Europe, investing £45 million to spice up manufacturing at its Barnstaple website.
University of Birmingham
Investing £10 million to determine a brand new biomanufacturing facility by way of its Precision Health Technologies Accelerator, accelerating the event of superior therapies.
Codis
Committing to put money into a brand new spray-drying facility in Haverhill, Suffolk to assist the manufacturing of next-generation medicines.
What they’re saying
“By manufacturing more medicines in this country we can make sure more people get the vital treatments they need. These investments will make a real difference to people across the country and show our Life Sciences Sector Plan is bearing fruit.”
— Liz Kendall, Science and Technology Secretary
“I have seen first-hand the difference latest treatments can make to a patient’s life. These investments mean more people living with conditions like bipolar disorder will benefit from cutting-edge medicines – developed and manufactured right here in Britain.”
— Zubir Ahmed, Health Innovation and Safety Minister
“The LSIMF grant has helped to unlock new investment in our Barnstaple site which remains a strategic asset to the UK, providing 9% of all NHS medicines.”
— Paul Tredwell, Chief Executive Officer, Accord
“The UK, and particularly the West Midlands, urgently needs GMP cleanroom facilities to support the production of Advanced Therapy Medicinal Products and vaccines, including cell therapies and mRNA vaccines, as well as medicines for clinical trials. This new investment will allow us to achieve our point-of-care manufacturing ambitions, ensuring patients get access to the latest, most innovative medicines.”
— Professor Gino Martini, Chief Executive Officer, PHTA
“This milestone marks the next phase in Codis’ evolution as a global leader in spray drying and ASD. The PSD4 significantly expands our ASD capacity and gives customers dedicated commercial‑scale throughput to bring more life‑changing medicines to market.”
— Nicolas Fortin, Chief Executive Officer, Codis
What’s subsequent
The authorities can be saying a brand new Life Sciences Large Investment Portfolio scheme, which is able to work with firms ready to speculate over £250 million in life sciences tasks. This will supply Trusted Trader standing, streamlined purposes, and sustained engagement with UK Ministers to additional strengthen life sciences funding within the nation.
The takeaway
These investments display the UK authorities’s dedication to bolstering the nation’s life sciences sector and making certain sufferers have dependable entry to crucial medicines. By supporting regional life sciences clusters and superior manufacturing capabilities, the federal government is positioning the UK as a worldwide hub for innovation and a frontrunner within the growth and manufacturing of cutting-edge therapies.